IMA FY 2023 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$67M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M-41.3% YoY

Gross Profit

$8M88.9% margin

Operating Income

-$75M-823.3% margin

Net Income

-$68M-744.2% margin

EPS (Diluted)

$-1.63

Cash Flow

Operating Cash Flow

-$80M

Free Cash Flow

-$80M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$192M

Total Liabilities

$22M

Stockholders' Equity

$170M

Cash & Equivalents

$120M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$16M	-41.3%
Gross Profit	$8M	-$49M	+116.7%
Operating Income	-$75M	-$71M	-6.4%
Net Income	-$68M	-$69M	+0.9%